(Photo: iStock)

The Medicines and Health products Regulatory Agency (MHRA) has issued a class two medicines recall for Oxylan 40mg prolonged-release tablets of GL Pharma.

GL Pharma is recalling the below batch of the tablets due to out of specification results for dissolution obtained during routine stability testing.

Product Details
Oxylan 40mg prolonged-release tablets, PL 21597/0064
Active pharmaceutical ingredient: Oxycodone Hydrochloride

Batch Number Expiry Date Pack Size First Distributed
9F119A 31/05/2024 56 02/06/2020

 

The healthcare professionals have been adviced to stop supplying the batch immediately and remove it from the shelves within the pharmacy.

It has also been suggested to quarantine all remaining stock and return it to the supplier using approved process.

If you want to share your stories and/or experiences with us, please send an email to [email protected]

LEAVE A REPLY